Table of Content
CHAPTER 1. INTRODUCTION
1.1. RESEARCH METHODOLOGY
1.1.1. ERC desk research
1.1.2. ERC data synthesis
1.1.3. Data validation and market feedback
1.1.4. ERC data sources
CHAPTER 2. EUROPE HUMAN PRIMARY CELL MARKET KEY INSIGHTS
2.1. RESEARCH SUMMARY AND SCOPE 25
2.2. HUMAN PRIMARY CELL PRODUCTION (MILLION CELLS), 1725
2.2.1. Europe Human Primary Cells Production (Million Cells) (17-25)
2.3. HUMAN PRIMARY CELL CONSUMPTION (MILLION CELLS), 1725
2.3.1. Europe Human Primary Cells Consumption (Million Cells) (17-25)
2.4. HUMAN PRIMARY CELL REVENUE (MILLION USD), 17-25
2.4.1. Europe Human Primary Cells Revenue (Million USD) (17-25)
CHAPTER 3. HUMAN PRIMARY CELL MARKET DYNAMICS
3.1. MARKET DETERMINANTS
CHAPTER 4. EUROPE HUMAN PRIMARY CELL MARKET BY TYPE
4.1. SEGMENT OUTLINE AND MARKET SHARE BY TYPE
4.2. EUROPE HUMAN PRIMARY CELL MARKET REVENUE (MILLION USD) & PRODUCTION VOLUME (CELLS) BY TYPE, 17-25
4.2.1. Europe Human Primary Cell Market Revenue (Million USD) By Type, 17-25
4.2.2. Europe Human Primary Cell Production (Million Cells) By Type, 17-25
4.3. BLOOD (PERIPHERAL) CELLS
4.3.1. Market Growth Indicators
4.3.2. Market Revenue (Million USD), Sales And Production Volume (Million Cells), 17 25
4.4. ENDOTHELIAL CELLS
4.4.1. Market Growth Indicators
4.4.2. Market Revenue (Million USD), Sales And Production Volume (Million Cells), 17 25
4.5. EPITHELIAL CELLS
4.5.1. Market Growth Indicators
4.5.2. Market Revenue (Million USD), Sales And Production Volume (Million Cells), 17 25
4.6. FIBROBLAST CELLS
4.6.1. Market Growth Indicators
4.6.2. Market Revenue (Million USD), Sales And Production Volume (Million Cells), 17 25
4.7. HEPACTOCYTE CELLS
4.7.1. Market Growth Indicators
4.7.2. Market Revenue (Million USD), Sales And Production Volume (Million Cells), 17 25
4.8. KERATINOCYTE CELLS
4.8.1. Market Growth Indicators
4.8.2. Market Revenue (Million USD), Sales And Production Volume (Million Cells), 17 25
4.9. MELANOCYTE CELLS
4.9.1. Market Growth Indicators
4.9.2. Market Revenue (Million USD), Sales And Production Volume (Million Cells), 17 25
4.10. PANCREATIC CELLS
4.10.1. Market Growth Indicators
4.10.2. Market Revenue (Million USD), Sales And Production Volume (Million Cells), 17 25
4.11. SMOOTH MUSCLE CELLS
4.11.1. Market Growth Indicators
4.11.2. Market Revenue (Million USD), Sales And Production Volume (Million Cells), 17 25
4.12. SKELETAL CELLS
4.12.1. Market Growth Indicators
4.12.2. Market Revenue (Million USD), Sales And Production Volume (Million Cells), 17 25
4.13. ADIPOCYTE CELLS
4.13.1. Market Growth Indicators
4.13.2. Market Revenue (Million USD), Sales And Production Volume (Million Cells), 17 25
CHAPTER 5. EUROPE HUMAN PRIMARY CELL MARKET BY APPLICATION
5.1. SEGMENT OUTLINE AND MARKET SHARE BY APPLICATION 52
5.2. EUROPE HUMAN PRIMARY CELL MARKET REVENUE (MILLION USD) BY APPLICATION, 17-25
5.3. CLINICAL
5.3.1. Market growth indicators
5.3.2. Market revenue (Million USD), 17 25
5.4. MEDICAL 55
5.4.1. Market growth indicators
5.4.2. Market revenue (Million USD), 17 25
5.5. ESTIMATED SHARE (%) OF HUMAN PRIMARY CELL TYPES IN POTENTIAL APPLICATIONS
CHAPTER 6. EUROPE HUMAN PRIMARY CELL MARKET BY COUNTRIES
6.1. SEGMENT OUTLINE AND MARKET SHARE BY COUNTRIES
6.2. EUROPE HUMAN PRIMARY CELL MARKET REVENUE, PRODUCTION & SALES BY COUNTRIES, 17-25
6.2.1. Europe Human Primary Cell Market Revenue (Million USD) By Countries, 17-25
6.2.2. Europe Human Primary Cell Production (Million Cells) By Countries, 17-25
6.2.3. Europe Human Primary Cell Market Sales (Million Cells) By Countries, 17-25
6.3. GERMANY 63
6.3.1. List of Potential Human Primary Cells Customers in Germany
6.3.2. Germany Human Primary Cell Market Revenue (Million USD), Production (Million Cells) & Sales (Million Cells) By Type, 17-25
6.3.3. Germany Human Primary Cell Revenue (Million USD) And Growth Rate By Type (17-25)
6.3.4. Germany Human Primary Cell Production (Million Cells) And Growth Rate By Type (17-25)
6.4. FRANCE 68
6.4.1. List of Potential Human Primary Cells Customers in France
6.4.2. France Human Primary Cell Market Revenue (Million USD), Production (Million Cells) & Sales (Million Cells) By Type, 17-25
6.4.3. France Human Primary Cell Revenue (Million USD) And Growth Rate By Type (17-25) 71
6.4.4. France Human Primary Cell Production (Million Cells) And Growth Rate By Type (17-25)
6.5. UK
6.5.1. List of Potential Human Primary Cells Customers in UK
6.5.2. UK Human Primary Cell Market Revenue (Million USD), Production (Million Cells) & Sales (Million Cells) By Type, 17-25
6.5.3. UK Human Primary Cell Revenue (Million USD) And Growth Rate By Type (17-25)
6.5.4. UK Human Primary Cell Production (Million Cells) And Growth Rate By Type (17-25)
6.6. ITALY
6.6.1. List of Potential Human Primary Cells Customers in Italy
6.6.2. Italy Human Primary Cell Market Revenue (Million USD), Production (Million Cells) & Sales (Million Cells) By Type, 17-25
6.6.3. Italy Human Primary Cell Revenue (Million USD) And Growth Rate By Type (17-25)
6.6.4. Italy Human Primary Cell Production (Million Cells) And Growth Rate By Type (17-25)
6.7. SPAIN 82
6.7.1. List of Potential Human Primary Cells Customers in Spain
6.7.2. Spain Human Primary Cell Market Revenue (Million USD), Production (Million Cells) & Sales (Million Cells) By Type, 17-25
6.7.3. Spain Human Primary Cell Revenue (Million USD) And Growth Rate By Type (17-25)
6.7.4. Spain Human Primary Cell Production (Million Cells) And Growth Rate By Type (17-25)
6.8. BENELUX 86
6.8.1. List of Potential Human Primary Cells Customers in Benelux
6.8.2. Benelux Human Primary Cell Market Revenue (Million USD), Production (Million Cells) & Sales (Million Cells) By Type, 17-25
6.8.3. Benelux Human Primary Cell Revenue (Million USD) And Growth Rate By Type (17-25)
6.8.4. Benelux Human Primary Cell Production (Million Cells) And Growth Rate By Type (17-25)
6.9. RUSSIA 92
6.9.1. List of Potential Human Primary Cells Customers in Russia
6.9.2. Russia Human Primary Cell Market Revenue (Million USD), Production (Million Cells) & Sales (Million Cells) By Type, 17-25
6.9.3. Russia Human Primary Cell Revenue (Million USD) And Growth Rate By Type (17-25)
6.9.4. Russia Human Primary Cell Production (Million Cells) And Growth Rate By Type (17-25)
6.10. REST OF EUROPE 97
6.10.1. List of Potential Human Primary Cells Customers in Rest of Europe
6.10.2. Rest of Europe Human Primary Cell Market Revenue (Million USD), Production (Million Cells) & Sales (Million Cells) By Type, 17-25
6.10.3. Rest of Europe Human Primary Cell Revenue (Million USD) And Growth Rate By Type (17-25)
6.10.4. Rest of Europe Human Primary Cell Production (Million Cells) And Growth Rate By Type (17-25)
CHAPTER 7. EUROPE HUMAN PRIMARY CELLS MANUFACTURERS PROFILES/ANALYSIS
7.1. LONZA 102
7.1.1. Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2. Human Primary Cells Product Category, Application and Specification
7.1.2.1. HUMAN BONE MARROW CD+ PROGENITOR CELLS 103
7.1.2.2. HUMAN PERIPHERAL BLOOD CD14+ MONOCYTES CELLS
7.1.2.3. DERMAL MICROVASCULAR ENDOTHELIAL CELLS
7.1.2.4. HUMAN SKELETAL MUSCLE MYOBLASTS
7.1.2.5. HUMAN LUNG FIBROBLASTS
7.1.2.6. OTHER PRODUCTS
7.1.3. Business Overview
7.2. THERMO FISHER SCIENTIFIC
7.2.1. Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2. Human Primary Cells Product Category, Application and Specification
7.2.2.1. Human Mammary Epithelial Cells (HMEC)
7.2.2.2. Human Umbilical Vein Endothelial Cells (HUVEC )
7.2.3. Fibroblasts
7.2.4. Human Skeletal Myoblasts
7.2.5. Human Plateable Hepatocytes, 5-Donor
7.2.6. Other Products
7.2.7. Main Business/Business Overview
7.3. SIGMA-ALDRICH
7.3.1. Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2. Human Primary Cells Product Category, Application and Specification
7.3.2.1. Cryoplateable Primary Human Hepatocytes (MTOXH1002)
7.3.2.2. Cryopreserved Primary Human Hepatocytes Juvenile (MTOXH1012)
7.3.2.3. Human Aortic Endothelial Cells (HAOEC)
7.3.2.4. Human Peripheral Blood T Cells (HPBT)
7.3.3. Main Business/Business Overview 109
7.4. CELL BIOLOGICS
7.4.1. Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.4.2. Human Primary Cells Product Category, Application and Specification
7.4.2.1. HUMAN PRIMARY AORTIC ENDOTHELIAL CELLS
7.4.2.2. HUMAN PRIMARY AORTIC FIBROBLASTS
7.4.2.3. Human Hepatic Stellate Cells
7.4.2.4. Human Primary Alveolar Epithelial Cells
7.4.3. Main Business/Business Overview
7.5. PROMOCELL GMBH
7.5.1. Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.5.2. Human Primary Cells Product Category, Application and Specification
7.5.2.1. Melanocytes
7.5.2.2. Cardiac Myocytes
7.5.2.3. Skeletal Muscle Cells
7.5.2.4. Osteoblasts
7.5.3. Other Products
7.5.4. Main Business/Business Overview
7.6. CURELINE
7.6.1. Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.6.2. Human Primary Cells Product Category, Application and Specification
7.6.2.1. Primary Cell Lines
7.6.3. Main Business/Business Overview
7.7. ZEN-BIO 116
7.7.1. Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.7.2. Human Primary Cells Product Category, Application and Specification
7.7.2.1. Human Adult Melanocytes
7.7.2.2. Adult Stem Cells
7.7.2.3. Human Dermal Fibroblasts
7.7.2.4. Human Mesothelial Cells
7.7.3. Other Products
7.7.4. Main Business/Business Overview
7.8. STEMCELL TECHNOLOGIES
7.8.1. Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.8.2. Human Primary Cells Product Category, Application and Specification
7.8.2.1. Human Peripheral Blood Monocytes
7.8.2.2. Human Platelet Lysate, Fibrinogen-Depleted
7.8.2.3. Human Cord Blood Mononuclear Cells
7.8.2.4. iCell® Cardiac Progenitor Cells
7.8.3. Other Products
7.8.4. Main Business/Business Overview
7.9. CELL APPLICATIONS
7.9.1. Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.9.2. Human Primary Cells Product Category, Application and Specification
7.9.2.1. Human Hair Follicle Dermal Papilla Cells
7.9.2.2. Chondrocyte
7.9.2.3. Keratinocyte
7.9.3. Other Products 1
7.9.4. Main Business/Business Overview
7.10. CREATIVE BIOARRAY
7.10.1. COMPANY BASIC INFORMATION, MANUFACTURING BASE, SALES AREA AND ITS COMPETITORS
7.10.2. HUMAN PRIMARY CELLS PRODUCT CATEGORY, APPLICATION AND SPECIFICATION
7.10.2.1. Human Synovial Membrane Fibroblasts
7.10.2.2. Human Leptomeningeal Pericytes
7.10.2.3. ADIPOSE CELLS
7.10.2.4. SKELETAL CELLS
7.10.2.5. PERIPHERAL BLOOD CELLS
7.10.3. Other Products
7.10.4. Main Business/Business Overview
7.11. REPROCELL EUROPE LTD.
7.11.1. COMPANY BASIC INFORMATION, MANUFACTURING BASE, SALES AREA AND ITS COMPETITORS
7.11.2. HUMAN PRIMARY CELLS PRODUCT CATEGORY, APPLICATION AND SPECIFICATION
7.11.2.1. ES/IPS CELLS
7.11.2.2. IMATRIX-2 STEM CELL CULTURE SUBSTRATE
7.11.3. Main Business/Business Overview
7.12. TEBU-BIO
7.12.1. COMPANY BASIC INFORMATION, MANUFACTURING BASE, SALES AREA AND ITS COMPETITORS
7.12.2. HUMAN PRIMARY CELLS PRODUCT CATEGORY, APPLICATION AND SPECIFICATION
7.12.2.1. Human Aortic Endothelial Cells
7.12.2.2. HUMAN BRONCHIAL EPITHELIAL CELL
7.12.2.3. Human SMOOTH MUSCLE CELLS
7.12.3. Other Products
7.12.4. Main Business/Business Overview
CHAPTER 8. MARKET SHARE OF KEY VENDORS
8.1.1. Market Share of Key Vendors